Ken Griffin Sanara Med Tech Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$33.72 - $40.94 $86,795 - $105,379	-2,574 Reduced 24.26%	8,038 $297,000
Q4 2023 Feb 14, 2024	BUY	$26.33 - $41.6 $24,829 - $39,228	943 Added 9.75%	10,612 $436,000
Q3 2023 Nov 14, 2023	SELL	$31.13 - $45.99 $256,635 - $379,141	-8,244 Reduced 46.02%	9,669 $300,000
Q2 2023 Aug 14, 2023	SELL	$33.54 - $49.68 $7,881 - $11,674	-235 Reduced 1.29%	17,913 $718,000
Q1 2023 May 15, 2023	BUY	$38.11 - $48.74 $212,577 - $271,871	5,578 Added 44.38%	18,148 $748,000
Q4 2022 Feb 14, 2023	SELL	$27.38 - $45.5 $61,933 - $102,921	-2,262 Reduced 15.25%	12,570 $571,000
Q3 2022 Nov 14, 2022	BUY	$20.68 - $34.25 $80,197 - $132,821	3,878 Added 35.4%	14,832 $440,000

723K

Ticker SMTI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 8,303,730
Market Cap $292M
Description
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.